As enterprises rapidly embrace multimodal AI capable of understanding both text and images, security researchers are discovering that these powerful new capabilities introduce equally sophisticated ...
Abstract: Proper signal measurement and processing are crucial in electroencephalography (EEG)-based brain-computer interfaces (BCIs), as they form the basis of brain insight and precise BCI control.
Abstract: Achieving high classification accuracy in motor-imagery-based brain–computer interfaces (BCIs) requires substantial amounts of training data. A challenge arises because of the impracticality ...
Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...
Runs on Python 3.9 to 3.14 on Windows, Linux and MacOS. We recommend Python 3.10 for the best compatibility with plugins such as SAM autolabeling. Run python example_coco.py and open the printed URL ...
Macworld reports the Mac Studio M5 is expected to launch in October 2026, delayed from early 2026 due to global DRAM shortages affecting Apple’s supply chain. The new models will feature M5 Max and M5 ...
In settings such as after-school day services and child development support, the background of behaviors where children "have a meltdown" or "lash out" often hides the difficulty of properly ...
With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its generic version of Amarin’s fish oil-derived cardiovascular drug Vascepa does not ...
WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...
US Supreme Court Backs Generic Drugmaker in 'Skinny Label' Patent Case By Blake Brittain WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's generic version of Amarin Pharma's cardiovascular medication ...
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results